REICH SAMUEL J (CEO and CFO) purchased 5.3% of their position (11K shares) of SAB BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/30/2023ACC: 0000950170-23-066901
DirectorOfficer10% Owner· CEO and CFO
Since Jan 2021
+11K
Net shares
Net buyer
$9.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11K
Price / share
$0.89
Trade value
$9.84K
% of position
5.3%
11/29/2023
208K→219K
Total
Net shares
+11K
Net value
$9.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/29/2023 | P · Purchase | +11K | $0.89 | $9.84K | 5.3% | 208K | 219K |
| Total | +11K | $9.84K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned547.70K
Total
547.70K indirect547.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 547.70K | Indirect |
| Total | 547.70K | 547.70K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported